|
|
|
| Treatment & Prevention > Prediabetic Conditions |
|
Treatment of Metabolic Syndrome
Certain metabolic disturbances grouped together in a single individual patient comprise the cluster known as metabolic syndrome. The National Cholesterol Education Program Expert Panel of the National Institutes of Health, National Heart, Lung, and Blood Institute, defines these metabolic disturbances as abdominal obesity, atherogenic dyslipidemia, sustained elevated blood pressure (>140/90 mm Hg), insulin resistance ± glucose intolerance, prothrombotic state, or proinflammatory state. Several factors together increase the risk of coronary heart disease, and insulin resistance combined with the other factors is a primary cause of Type 2 diabetes. Obesity, physical inactivity, and genetic factors are the root causes of metabolic syndrome In the US, 21.8% of the population is estimated to have metabolic syndrome.
|
Treatment of Prediabetes
Prediabetes is the subclinical state during which glucose levels are too high to be considered normal but not high enough to meet the diagnostic criteria for type 2 diabetes. Diabetes is known to have a long preclinical phase of approximately 10 to 12 years, during which period of time metabolic changes may already be causing microvascular and macrovascular complications. Therefore, the creation of the subclinical category of prediabetes represented an important step in efforts to prevent or delay the onset of diabetes. In short, treatment of prediabetes is synonymous with the prevention or delay of Type 2 diabetes.
|
|
|
